ライフサイエンスコーパス: luteinize

1 Serum-luteinizing and follicle-stimulating hormone levels were

2 hether IFNT directly affects the function of luteinized bovine granulosa cells (LGCs), a model for la

3 lomic analysis of serum and whole-blood from luteinizing/follicle-stimulating (LH/FSH)-secreting (n =

4 sive apoptotic staining in unruptured poorly luteinized follicles, consistent with dramatic reduction

5 ol <184 pmol/l (50 pg/ml), FSH <10 IU/l, and luteinizing hormone <10 IU/l, was significantly more pre

6 , and lower follicle-stimulating hormone and luteinizing hormone (each P < .01).

7 tein-coupled receptors (GPCRs), activated by luteinizing hormone (hLH) and essentially involved in th

8 Human luteinizing hormone (hLH) and human chorionic gonadotrop

9 he number of days from the midcycle surge in luteinizing hormone (LH) (P=.008).

10 s thought to be indirectly controlled by the luteinizing hormone (LH) acting through the LH/choriogon

11 Luteinizing hormone (LH) activates protein kinase A (PKA

12 Meiosis in mammalian oocytes is paused until luteinizing hormone (LH) activates receptors in the mura

13 Luteinizing hormone (LH) acts on ovarian follicles to re

14 The signaling pathway by which luteinizing hormone (LH) acts on the somatic cells of ve

15 with consequent diminished levels of plasma luteinizing hormone (LH) and correspondingly attenuated

16 esis and secretion of gonadotropic hormones, luteinizing hormone (LH) and follicle stimulating hormon

17 osynthesis and release of the gonadotropins, luteinizing hormone (LH) and follicle stimulating hormon

18 Luteinizing hormone (LH) and follicle-stimulating hormon

19 ith gonadotropic endocrine cells [expressing luteinizing hormone (LH) and follicle-stimulating hormon

20 close to follicle-stimulating hormone (FSH), luteinizing hormone (LH) and growth hormone (GH) cells.

21 ve" group (21%-23%), characterized by higher luteinizing hormone (LH) and sex hormone binding globuli

22 n, serum follicle stimulating hormone (FSH), luteinizing hormone (LH) and testosterone levels or test

23 In GnRH-CREB KO mice, basal levels of luteinizing hormone (LH) and the postovariectomy increme

24 of gonadotropin releasing hormone (GnRH) and luteinizing hormone (LH) are pivotal events in female re

25 FSH and luteinizing hormone (LH) are secreted constitutively or

26 oma cells were treated with the gonadotropin luteinizing hormone (LH) at concentrations equivalent to

27 The half-life for luteinizing hormone (LH) clearance increases in Mrc1(-/-

28 validate AutoDecon for application to serum luteinizing hormone (LH) concentration time series using

29 A surge of luteinizing hormone (LH) from the pituitary gland trigge

30 (GNRH)-stimulated synthesis and secretion of luteinizing hormone (LH) from the pituitary gonadotroph.

31 ating follicle-stimulating hormone (FSH) and luteinizing hormone (LH) gene expression in the pituitar

32 inhibited the kisspeptin-induced release of luteinizing hormone (LH) in rats and mice and blocked th

33 bone age versus the baseline measurement of luteinizing hormone (LH) in serum, used as the reference

34 or tissue remodeling process is triggered by luteinizing hormone (LH) in the ovarian follicle.

35 and then augments (positive feedback) serum luteinizing hormone (LH) increased Kiss1 mRNA density an

36 Luteinizing hormone (LH) induces maturational processes

37 The pulsatile release of luteinizing hormone (LH) is critical for mammalian ferti

38 Synthesis of luteinizing hormone (LH) is tightly controlled by a comp

39 c mouse strain that has chronically elevated luteinizing hormone (LH) levels (LH-CTP).

40 along with minimal repression of circulating luteinizing hormone (LH) levels and no change in the lip

41 n, follicular stimulating hormone (FSH), and luteinizing hormone (LH) levels were measured.

42 etion of GnRH is also reduced as basal serum luteinizing hormone (LH) levels were significantly lower

43 he fabrication of a nanosensor for detecting luteinizing hormone (LH) of sheep using a gold nanoparti

44 To determine whether the action of luteinizing hormone (LH) on the mouse ovarian follicle c

45 Luteinizing hormone (LH) pulsatility, body weight, ovari

46 Adult obesity is associated with blunted luteinizing hormone (LH) pulse amplitude that is partial

47 fertility, is associated with an increase in luteinizing hormone (LH) pulse frequency, implicating ab

48 from adults with previous reports of in vivo luteinizing hormone (LH) pulse frequency.

49 r cells in that they were 3betaHSD-negative, luteinizing hormone (LH) receptor (LHR)-negative, and pl

50 Recent studies suggest that luteinizing hormone (LH) receptor activation leads to tr

51 licular development, including expression of luteinizing hormone (LH) receptor by the granulosa cells

52 , an intracellular messenger formed when the luteinizing hormone (LH) receptor is activated.

53 l mechanisms play a major role in regulating luteinizing hormone (LH) receptor mRNA expression in the

54 eral motions of individual FLAG-tagged human luteinizing hormone (LH) receptors expressed on CHO cell

55 ave examined their ability to stimulate GnRH/luteinizing hormone (LH) release after peripheral or cen

56 atography was identified as OIF by eliciting luteinizing hormone (LH) release and ovulation in llamas

57 induces negative feedback on pulsatile GnRH/luteinizing hormone (LH) release and positive feedback g

58 r the female-typical cyclic surge pattern of luteinizing hormone (LH) release.

59 provides the drive necessary for tonic GnRH/luteinizing hormone (LH) release.

60 acy and duration of action) of inhibition of luteinizing hormone (LH) release.

61 easing hormone (GnRH) neurons and subsequent luteinizing hormone (LH) release.

62 es.RESULTSIn healthy women, the amplitude of luteinizing hormone (LH) rise was similar to that after

63 there is no information on the regulation of luteinizing hormone (LH) secretion by NKB or its recepto

64 positive and negative feedback control over luteinizing hormone (LH) secretion during the ovulatory

65 Locomotor activity and luteinizing hormone (LH) secretion in golden hamsters sh

66 istration of senktide (NK3R agonist) induced luteinizing hormone (LH) secretion in prepubertal and pe

67 on of these neurons would generate pulsatile luteinizing hormone (LH) secretion in vivo.

68 s characterized by the pattern of endogenous luteinizing hormone (LH) secretion on the basis of frequ

69 Changes in luteinizing hormone (LH) secretion that are observed in

70 (GnRH) neurons, which in turn supports basal luteinizing hormone (LH) secretion.

71 se mice, suggesting a mechanism for low GnRH/luteinizing hormone (LH) secretion.

72 g and follicle-stimulating hormone (FSH) and luteinizing hormone (LH) secretion.

73 s of activation required to evoke a pulse of luteinizing hormone (LH) secretion.

74 Luteinizing hormone (LH) stimulates steroidogenesis larg

75 Although mammalian oocytes ovulated after luteinizing hormone (LH) stimulation can be fertilized a

76 riggers germinal vesicle breakdown after the luteinizing hormone (LH) surge and reentry into the meio

77 have demonstrated that IL-1beta inhibits the luteinizing hormone (LH) surge during the afternoon of p

78 e in the generation of the preovulatory GnRH/luteinizing hormone (LH) surge in the female rodent.

79 linked to the induction of the preovulatory luteinizing hormone (LH) surge in the rat.

80 ntained in prophase meiotic arrest until the luteinizing hormone (LH) surge induces reentry into the

81 ut not males, to display an estrogen-induced luteinizing hormone (LH) surge is consistent with the hi

82 sures repeatedly to predict the preovulatory luteinizing hormone (LH) surge is not practical.

83 provides for the timing of the preovulatory luteinizing hormone (LH) surge necessary for ovulation i

84 irregular estrous cycles, lack a coordinated luteinizing hormone (LH) surge on the day of proestrus,

85 to escalating levels of estrogen, express a luteinizing hormone (LH) surge that is prompted by a sur

86 GnRH) surge is a prerequisite signal for the luteinizing hormone (LH) surge that triggers ovulation.

87 The midcycle luteinizing hormone (LH) surge triggers several tightly

88 the DM, up to the stage of the preovulatory luteinizing hormone (LH) surge, is impaired.

89 induction of maturation by the preovulatory luteinizing hormone (LH) surge.

90 event underlying generation of the ovulatory luteinizing hormone (LH) surge.

91 tion is induced by the preovulatory surge of luteinizing hormone (LH) that acts on the ovary and trig

92 fully grown follicles, prior to the surge of luteinizing hormone (LH) that triggers meiotic resumptio

93 at clearance rates for glycoproteins such as luteinizing hormone (LH) that undergo regulated release

94 Luteinizing hormone (LH) via activation of protein kinas

95 Serum luteinizing hormone (LH) was likewise suppressed within

96 ), follicular stimulating hormone (FSH), and luteinizing hormone (LH) were measured.

97 n-deficient mice exhibit increased levels of luteinizing hormone (LH), a pituitary hormone that regul

98 d concentrations of estradiol, progesterone, luteinizing hormone (LH), and follicle-stimulating hormo

99 mones follicle-stimulating hormone (FSH) and luteinizing hormone (LH), and that ovarian steroids exer

100 pin's follicle-stimulating hormone (FSH) and luteinizing hormone (LH), both of which are heterodimers

101 In response to luteinizing hormone (LH), cGMP in the granulosa cells de

102 The gonadotropins, luteinizing hormone (LH), follicle-stimulating hormone (

103 Estradiol, estrone, testosterone, luteinizing hormone (LH), follicle-stimulating hormone (

104 BG), dehydroepiandrosterone sulfate (DHEAS), luteinizing hormone (LH), follicle-stimulating hormone (

105 Luteinizing hormone (LH), produced in the anterior lobe

106 pins, follicle-stimulating hormone (FSH) and luteinizing hormone (LH), under the control of pulsatile

107 ine, beta-endorphin, and enkephalin) inhibit luteinizing hormone (LH), vasopressin (VP), and oxytocin

108 In response to luteinizing hormone (LH), which binds to receptors on th

109 Dendrimer 3 showed similar luteinizing hormone (LH)-release activity to triptorelin

110 ensatory elevation in levels of gonadotropin luteinizing hormone (LH).

111 ins, follicle-stimulating hormone (FSH), and luteinizing hormone (LH).

112 t measured urinary estrone-3-glucuronide and luteinizing hormone (LH).

113 tes under the pulsatile control of pituitary luteinizing hormone (LH).

114 in calcium oscillations and the secretion of luteinizing hormone (LH).

115 tory follicles resume meiosis in response to luteinizing hormone (LH).

116 se hamster ovary cells expressing either the luteinizing hormone (LH)/chorionic gonadotropin (CG) or

117 ose demonstrating the presence of functional luteinizing hormone (LH)/hCG receptors in human breast c

118 to the pituitary and the resulting surge of luteinizing hormone (LH); however, the neural circuits t

119 r GalNAc to N-linked oligosaccharides on the luteinizing hormone alpha subunit and CA6 but not to tho

120 We measured follicle-stimulating hormone and luteinizing hormone and added information on menstrual p

121 oproteins including the glycoprotein hormone luteinizing hormone and carbonic anhydrase-6 (CA6).

122 A limited number of glycoproteins including luteinizing hormone and carbonic anhydrase-VI (CA6) bear

123 yp2j5 (-/-) mice, but their plasma levels of luteinizing hormone and follicle stimulating hormone wer

124 The pituitary glycoprotein hormones, luteinizing hormone and follicle-stimulating hormone (FS

125 ce also have decreased circulating levels of luteinizing hormone and follicle-stimulating hormone but

126 Pituitary (luteinizing hormone and follicle-stimulating hormone) an

127 pulsatile release of gonadotropin hormones (luteinizing hormone and follicle-stimulating hormone) fr

128 gent induced high levels of the gonadotropin luteinizing hormone and increased the serum concentratio

129 e time course or the plasma concentration of luteinizing hormone and its physiological effects on the

130 -releasing hormone (GnRH) induces a surge of luteinizing hormone and ovulation in a variety of specie

131 axis and, thus, normalizes hormone levels of luteinizing hormone and testosterone.

132 restores gonadotrophin secretion, as well as luteinizing hormone and thyroid-stimulating hormone puls

133 nadotropins follicle-stimulating hormone and luteinizing hormone are heterodimeric glycoproteins expr

134 estradiol, follicle-stimulating hormone, and luteinizing hormone around the woman's own mean levels w

135 e required for gonadotrope specification and luteinizing hormone beta (LH beta) gene expression.

136 hether MIP-2A can transcriptionally regulate luteinizing hormone beta (LHbeta), a pituitary-specific

137 riptional activation of both the FSHbeta and luteinizing hormone beta subunit (LHbeta) gene promoters

138 me on DNA and the binding of a TF, using the luteinizing hormone beta subunit gene (Lhb) promoter and

139 arche by regulating the transcription of the luteinizing hormone beta subunit.

140 utant mouse, whereas proopiomelanocortin and luteinizing hormone beta-subunit expression were normal

141 The luteinizing hormone chorionic gonadotropin receptor (LHC

142 ycle arrested at prophase of meiosis I until luteinizing hormone from the pituitary acts on the folli

143 onding with an increase in expression of the luteinizing hormone gene, Lhb We demonstrate that poorly

144 one less than 250 ng/dL (or 8.67 nmol/L) and luteinizing hormone greater than 9.85 IU/L, and LCD by t

145 by testosterone as 250 ng/dL or greater and luteinizing hormone greater than 9.85 IU/L.

146 Oral administration of 10b suppressed luteinizing hormone in castrated macaques.

147 ony between follicle-stimulating hormone and luteinizing hormone in the luteal phase.

148 hCGbeta evolved from the beta subunit of luteinizing hormone in two phases.

149 one administration results in suppression of luteinizing hormone in wild-type male mice, but paradoxi

150 arcuate nucleus, and a reduced compensatory luteinizing hormone increase compared with control anima

151 Maximal secretion of the gonadotropin Luteinizing Hormone is supported by GLUT1 expression and

152 er (13.4+/-3.2 nmol per liter, P<0.001), the luteinizing hormone level increased from 2.7+/-2.0 to 8.

153 one, follicle-stimulating hormone level, and luteinizing hormone level were measured and testicular h

154 had higher follicle-stimulating hormone and luteinizing hormone levels and lower estradiol levels at

155 with BAY 1214784 effectively lowered plasma luteinizing hormone levels by up to 49%, at the same tim

156 , E1, E1S, follicle-stimulating hormone, and luteinizing hormone levels in all patients and the propo

157 ale mice, but paradoxically stimulates serum luteinizing hormone levels in GPRC6A(-/-) null mice.

158 estrous cycles and elevated testosterone and luteinizing hormone levels, suggesting altered hypothala

159 strongly associates with PCOS diagnosis and luteinizing hormone levels.

160 varies lacking corpora lutea and increase in luteinizing hormone levels.

161 the fasting-associated decrease in overnight luteinizing hormone pulse frequency but had no effect on

162 creases in testosterone and the testosterone/luteinizing hormone ratio were detected in men watching

163 The human luteinizing hormone receptor (hLH-R) is a member of the

164 t study investigated regulation of the human luteinizing hormone receptor (hLHR) gene by histone deac

165 The luteinizing hormone receptor (LHR) and beta2-adrenergic

166 n hormones to their cognate human receptors (luteinizing hormone receptor (LHR) and thyroid-stimulati

167 n A (TSA), induces derepression of the human luteinizing hormone receptor (LHR) gene by de-recruitmen

168 Transcription of luteinizing hormone receptor (LHR) gene is activated by

169 ously demonstrated that transcription of the luteinizing hormone receptor (LHR) gene is subject to re

170 We have demonstrated that silencing of luteinizing hormone receptor (LHR) gene transcription is

171 the past decade, however, the expression of luteinizing hormone receptor (LHR) has also been reporte

172 Our previous studies have identified a luteinizing hormone receptor (LHR) mRNA-binding protein

173 mbined systematic mutagenesis studies at the luteinizing hormone receptor and the thyroid-stimulating

174 utant can inhibit signaling to G(s) from the luteinizing hormone receptor by 97% and from the calcito

175 s in the HinRs and the interhelical loops of luteinizing hormone receptor/follicle stimulating hormon

176 erize with its closely related receptor, the luteinizing hormone receptor; this association may have

177 PD-PALM of two functionally defined mutant luteinizing hormone receptors (LHRs), a ligand-binding d

178 as well as human chorionic gonadotropin and luteinizing hormone receptors on male breast tissue, may

179 Increased luteinizing hormone relative to follicle-stimulating hor

180 series induced a much prolonged increase of luteinizing hormone release compared to KP10 and increas

181 Inhibition of luteinizing hormone release over time was measured in th

182 n of prostaglandin E2, which then stimulates luteinizing hormone releasing hormone (LHRH) neurons to

183 dy single-chain variable fragment (scFv) and luteinizing hormone releasing hormone (LHRH) peptide, re

184 Cytotoxic analogue of luteinizing hormone releasing hormone (LHRH), AN-207, bi

185 Irradiation of luteinizing hormone releasing hormone (LHRH), growth hor

186 Bilateral orchiectomy or luteinizing hormone releasing hormone agonists are the r

187 Luteinizing hormone releasing hormone analog (LHRHa, des

188 ne and metabolic variables were measured and luteinizing hormone sampled over 8 hours on days 2 to 5

189 for estradiol-mediated suppression of tonic luteinizing hormone secretion (an indirect measure of Gn

190 crucial role in the regulation of pituitary luteinizing hormone secretion and reproduction.

191 Pulsatile luteinizing hormone secretion and spermatogenesis were d

192 rs in GnIH-ir nuclei, and GnIH inhibition of luteinizing hormone secretion indicate the discovery of

193 the stress-induced suppression in pulsatile luteinizing hormone secretion observed in control mice.

194 stent with a role in regulating preovulatory luteinizing hormone secretion, rostral projections from

195 ted a robust GnRH discharge, as reflected by luteinizing hormone secretion, which was abolished by pr

196 cocorticoid-induced suppression of pulsatile luteinizing hormone secretion.

197 In vivo GnIH administration rapidly inhibits luteinizing hormone secretion.

198 lels between MSP signaling in C. elegans and luteinizing hormone signaling in mammals.

199 g, n = 24; 12.8 nmol/kg, n = 24) to induce a luteinizing hormone surge and egg maturation.

200 otein increased >10-fold after the ovulatory luteinizing hormone surge in wild-type but not PRKO mice

201 t in the ovary for extended periods before a luteinizing hormone surge induces entry into the first m

202 eleasing hormone (GnRH) release triggers the luteinizing hormone surge that induces ovulation.

203 losa cells of periovulatory follicles by the luteinizing hormone surge through a progesterone recepto

204 han during the luteal phase (6-10 days after luteinizing hormone surge).

205 ein alters the amplitude of the preovulatory luteinizing hormone surge, likely by perturbing GnRH rel

206 n several hours after the ovulation-inducing luteinizing hormone surge, whereas they undergo differen

207 kisspeptin is involved in generation of the luteinizing hormone surge, which is required for ovulati

208 d by the puberty-triggering and preovulatory luteinizing hormone surge-mediating peptide, kisspeptin.

209 d for regulation of a full preovulatory-like luteinizing hormone surge.

210 expected time of the proestrous preovulatory luteinizing hormone surge.

211 n brain slices from a model exhibiting daily luteinizing hormone surges.

212 Luteinizing hormone then acts on receptors in outer gran

213 nts with abnormal levels of testosterone and luteinizing hormone was less pronounced-57% and 21%, res

214 estradiol, total and free testosterone, and luteinizing hormone were higher by 5.26% (95% CI: 1.27%,

215 We used transgenic mice that overexpress luteinizing hormone with subsequent ovarian hyperstimula

216 ed puberty associated with low or apulsatile luteinizing hormone) in both humans and in the mouse mod

217 rsting activity associated with the GnRH/LH (luteinizing hormone) surge.

218 ic antigen, thyroid stimulating hormone, and luteinizing hormone) were printed in an array format ont

219 ailure (low/normal testosterone and elevated luteinizing hormone).

220 strous mice that robust pulsatile release of luteinizing hormone, a proxy for GnRH, emerges abruptly

221 Ratios of follicle stimulating hormone to luteinizing hormone, a sexual maturity indicator, in all

222 sisting of an alpha subunit, also present in luteinizing hormone, and a unique beta subunit, which is

223 ormones: human chorionic gonadotropin, human luteinizing hormone, and follicle stimulating hormone by

224 Estradiol, progesterone, luteinizing hormone, and follicle-stimulating hormone we

225 erum levels of CRP, estradiol, progesterone, luteinizing hormone, and follicle-stimulating hormone we

226 droepiandrosterone (DHEAS), androstenedione, luteinizing hormone, and follicle-stimulating hormone.

227 d levels of follicle-stimulating hormone and luteinizing hormone, and increased variability of estrad

228 owth factor 1, follicle-stimulating hormone, luteinizing hormone, and testosterone levels).

229 for zonulin and antibodies against GnRH and luteinizing hormone, and their receptors.

230 l follicles, independently of an increase in luteinizing hormone, and this phenotype can be reversed

231 energy, vitamin E intake, physical activity, luteinizing hormone, follicle-stimulating hormone, and p

232 nophore-induced acrosome reaction as well as luteinizing hormone, follicle-stimulating hormone, and t

233 Estradiol, progesterone, luteinizing hormone, follicle-stimulating hormone, sex h

234 t explained by any deficits in testosterone, luteinizing hormone, or follicle-stimulating hormone con

235 ens, disrupted reproductive cycles, and high luteinizing hormone, the latter reflecting increased gon

236 tes pituitary synthesis of a large amount of luteinizing hormone, which is required for ovulation.

237 Tight regulation of luteinizing hormone-beta subunit (LHbeta) expression is

238 e generated by breeding MMTV-Neu mice with a luteinizing hormone-overexpressing mouse model of ovaria

239 /23), mainly in follicle-stimulating hormone/luteinizing hormone-producing (38%) and null cell (57%)

240 ombesin (AN-215), somatostatin (AN-238), and luteinizing hormone-releasing hormone (AN-207) consisted

241 Treatment with antagonists of luteinizing hormone-releasing hormone (LH-RH) leads to d

242 Treatment with a luteinizing hormone-releasing hormone (LHRH) agonist inc

243 orticotropic hormone (ACTH) and hypothalamic luteinizing hormone-releasing hormone (LHRH) agonist, [D

244 Ovarian suppression with luteinizing hormone-releasing hormone (LHRH) agonists is

245 the recent developments on BPH therapy with luteinizing hormone-releasing hormone (LHRH) antagonist

246 tance and (5) a modified synthetic analog of luteinizing hormone-releasing hormone (LHRH) as a target

247 gs (prodigiosin or paclitaxel) conjugated to Luteinizing Hormone-Releasing Hormone (LHRH) for the spe

248 These drugs were functionalized with Luteinizing Hormone-Releasing hormone (LHRH) ligands who

249 Functionalized with luteinizing hormone-releasing hormone (LHRH) peptide via

250 Importantly, SSA induced by luteinizing hormone-releasing hormone (LHRH) receptor an

251 estigate the mechanism by which Mn2+ induces luteinizing hormone-releasing hormone (LHRH) secretion f

252 s by which the neuroendocrine brain controls luteinizing hormone-releasing hormone (LHRH) secretion.

253 Luteinizing hormone-releasing hormone (LHRH) was used as

254 large doses of Cetrorelix, an antagonist of luteinizing hormone-releasing hormone (LHRH), reduces le

255 naling pathway that prompts the secretion of luteinizing hormone-releasing hormone (LHRH), the neurop

256 ne (LH) surge that is prompted by a surge in luteinizing hormone-releasing hormone (LHRH).

257 othalamic neurons secreting the neuropeptide luteinizing hormone-releasing hormone (LHRH).

258 ng afferent pathways to neurons synthesizing luteinizing hormone-releasing hormone (LHRH, also known

259 (68)Ga-PSMA-11 PET imaging in hormone-naive (luteinizing hormone-releasing hormone [LHRH] +/- bicalut

260 itive tumors also received letrozole (plus a luteinizing hormone-releasing hormone [LHRH] agonist if

261 diation plus immediate androgen suppression (luteinizing hormone-releasing hormone [LHRH] agonist), w

262 steroid ablation using leuprolide acetate, a luteinizing hormone-releasing hormone agonist (LHRHa), i

263 d) (PLGA) microspheres encapsulating a model luteinizing hormone-releasing hormone agonist (LHRHa)-ba

264 Luteinizing hormone-releasing hormone agonist (LHRHa; le

265 AST, which was defined as 6 months of both a luteinizing hormone-releasing hormone agonist and an ant

266 ts receiving combined androgen blockade with luteinizing hormone-releasing hormone agonist and bicalu

267 les, followed by total androgen suppression (luteinizing hormone-releasing hormone agonist plus bical

268 n deprivation (AD) to cixutumumab added to a luteinizing hormone-releasing hormone agonist with bical

269 S; two injections of every-3-months depot of luteinizing hormone-releasing hormone agonist) to primar

270 Patients were randomly assigned 2:1 to a luteinizing hormone-releasing hormone agonist, bicalutam

271 Injectable luteinizing hormone-releasing hormone agonists (e.g., le

272 Bilateral orchiectomy or luteinizing hormone-releasing hormone agonists are recom

273 ; and three, when chemical suppression using luteinizing hormone-releasing hormone agonists is the ch

274 of 5 ng per milliliter or higher received a luteinizing hormone-releasing hormone analogue and an an

275 Whether the administration of luteinizing hormone-releasing hormone analogues (LHRHa)

276 s monotherapy or with adjuvant castration or luteinizing hormone-releasing hormone superagonists to b

277 k suggests that cytotoxic peptide analogs of luteinizing hormone-releasing hormone, somatostatin, and

278 hormone-secreting (GH-secreting) GH3 cells, luteinizing hormone-secreting (LH-secreting) LbetaT2 cel

279 e, thereby inhibiting the proestrus surge in luteinizing hormone.

280 gesterone, follicle-stimulating hormone, and luteinizing hormone.

281 iosynthesis before the preovulatory surge of luteinizing hormone.

282 d all had abnormal secretion of GnRH-induced luteinizing hormone.

283 in a significant decrease in serum levels of luteinizing hormone.

284 ted by the downstream pulsatile secretion of luteinizing hormone.

285 and lower levels of endogenous estradiol and luteinizing hormone.

286 ine 3 (Org 41841), a partial agonist for the luteinizing hormone/choriogonadotropin receptor (LHCGR)

287 Signaling by the luteinizing hormone/choriogonadotropin receptor (LHR) is

288 We tested here, using hypogonadal luteinizing hormone/choriongonadotropin receptor (LHCGR)

289 identified previously as an agonist for the luteinizing hormone/chorionic gonadotropin receptor (LHC

290 mical analysis colocalized expression of the luteinizing hormone/chorionic gonadotropin receptor, PRO

291 Activation of the luteinizing hormone/human chorionic gonadotropin (LH/hCG

292 third transmembrane alpha-helix (TM3) of the luteinizing hormone/human chorionic gonadotropin recepto

293 ecreased circulating testosterone, increased luteinizing hormone/testosterone ratio, and decreased ex

294 ollicular differentiation markers, including luteinizing-hormone receptor (LHR), inhibin-alpha, micro

295 increased levels of follicle stimulating and luteinizing hormones, and 8.52-fold increased risk of Le

296 ted with high follicle-stimulating (FSH) and luteinizing (LH) hormone levels.

297 5a prevents follicle-stimulating hormone and luteinizing protein from up-regulating the CTNNB1 and CR

298 The mutant stromal cells consist of a luteinized theca cell lineage at various differentiation

299 inducing cells, the identification of mutant luteinized theca cells may add crucial evidence in under

300 ether, our results suggest that GT198 mutant luteinized theca cells overexpressing CYP17 are common i